Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans
Abstract Introduction One‐third of Medicare beneficiaries are enrolled in Medicare Advantage (MA). Yet, little is known about MA beneficiaries diagnosed with Alzheimer's disease (AD) and AD‐related dementias (AD/ADRD). Methods We calculated the prevalence of AD/ADRD diagnoses in 2014 and 2016 i...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring |
Subjects: | |
Online Access: | https://doi.org/10.1002/dad2.12048 |
id |
doaj-1548c96c22824f1caa0c0657b7815845 |
---|---|
record_format |
Article |
spelling |
doaj-1548c96c22824f1caa0c0657b78158452021-04-15T14:35:47ZengWileyAlzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring2352-87292020-01-01121n/an/a10.1002/dad2.12048Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plansEric Jutkowitz0Julie P.W. Bynum1Susan L. Mitchell2Noelle M. Cocoros3Oren Shapira4Kevin Haynes5Vinit P. Nair6Cheryl N. McMahill‐Walraven7Richard Platt8Ellen P. McCarthy9Department of Health Services Policy & Practice Brown University School of Public Health Providence Rhode Island 02912 USADepartment of Internal Medicine University of Michigan Ann Arbor Michigan USAHebrew Senior Life Hinda and Arthur Marcus Institute for Aging Research Boston Massachusetts USADepartment of Population Medicine Harvard Pilgrim Health Care Institute Boston Massachusetts USADepartment of Population Medicine Harvard Pilgrim Health Care Institute Boston Massachusetts USADepartment of Scientific Affairs Health Core, Inc. Wilmington Delaware USAHumana Healthcare Research Humana Inc. Louisville Kentucky USAHealthagen LLC part of the CVS Health family of companies Blue Bell Pennsylvania USADepartment of Population Medicine Harvard Pilgrim Health Care Institute Boston Massachusetts USAHebrew Senior Life Hinda and Arthur Marcus Institute for Aging Research Boston Massachusetts USAAbstract Introduction One‐third of Medicare beneficiaries are enrolled in Medicare Advantage (MA). Yet, little is known about MA beneficiaries diagnosed with Alzheimer's disease (AD) and AD‐related dementias (AD/ADRD). Methods We calculated the prevalence of AD/ADRD diagnoses in 2014 and 2016 in three MA plans. We determined the demographic characteristics of beneficiaries diagnosed with AD/ADRD, and whether they disenrolled from the MA plan for any reason within 364 days from the index date. Results In 2014 and 2016, the overall prevalence of AD/ADRD diagnoses was 5.6% and 6.5%, respectively. In 2016, AD/ADRD beneficiaries were on average 82.4 (SD = 7.4) years of age, 61.8% female, and had multiple comorbidities. By 364 days post‐index date, 32% of beneficiaries with AD/ADRD had disenrolled from their plan. The demographic characteristics of 2014 beneficiaries with diagnosed AD/ADRD were similar to their 2016 counterparts. Discussion The prevalence of AD/ADRD diagnosis in MA is lower than rates reported in Medicare fee‐for‐service.https://doi.org/10.1002/dad2.12048MedicareMedicare Advantagedementia, Alzheimer's diseasemild cognitive impairment |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Eric Jutkowitz Julie P.W. Bynum Susan L. Mitchell Noelle M. Cocoros Oren Shapira Kevin Haynes Vinit P. Nair Cheryl N. McMahill‐Walraven Richard Platt Ellen P. McCarthy |
spellingShingle |
Eric Jutkowitz Julie P.W. Bynum Susan L. Mitchell Noelle M. Cocoros Oren Shapira Kevin Haynes Vinit P. Nair Cheryl N. McMahill‐Walraven Richard Platt Ellen P. McCarthy Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring Medicare Medicare Advantage dementia, Alzheimer's disease mild cognitive impairment |
author_facet |
Eric Jutkowitz Julie P.W. Bynum Susan L. Mitchell Noelle M. Cocoros Oren Shapira Kevin Haynes Vinit P. Nair Cheryl N. McMahill‐Walraven Richard Platt Ellen P. McCarthy |
author_sort |
Eric Jutkowitz |
title |
Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans |
title_short |
Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans |
title_full |
Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans |
title_fullStr |
Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans |
title_full_unstemmed |
Diagnosed prevalence of Alzheimer's disease and related dementias in Medicare Advantage plans |
title_sort |
diagnosed prevalence of alzheimer's disease and related dementias in medicare advantage plans |
publisher |
Wiley |
series |
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring |
issn |
2352-8729 |
publishDate |
2020-01-01 |
description |
Abstract Introduction One‐third of Medicare beneficiaries are enrolled in Medicare Advantage (MA). Yet, little is known about MA beneficiaries diagnosed with Alzheimer's disease (AD) and AD‐related dementias (AD/ADRD). Methods We calculated the prevalence of AD/ADRD diagnoses in 2014 and 2016 in three MA plans. We determined the demographic characteristics of beneficiaries diagnosed with AD/ADRD, and whether they disenrolled from the MA plan for any reason within 364 days from the index date. Results In 2014 and 2016, the overall prevalence of AD/ADRD diagnoses was 5.6% and 6.5%, respectively. In 2016, AD/ADRD beneficiaries were on average 82.4 (SD = 7.4) years of age, 61.8% female, and had multiple comorbidities. By 364 days post‐index date, 32% of beneficiaries with AD/ADRD had disenrolled from their plan. The demographic characteristics of 2014 beneficiaries with diagnosed AD/ADRD were similar to their 2016 counterparts. Discussion The prevalence of AD/ADRD diagnosis in MA is lower than rates reported in Medicare fee‐for‐service. |
topic |
Medicare Medicare Advantage dementia, Alzheimer's disease mild cognitive impairment |
url |
https://doi.org/10.1002/dad2.12048 |
work_keys_str_mv |
AT ericjutkowitz diagnosedprevalenceofalzheimersdiseaseandrelateddementiasinmedicareadvantageplans AT juliepwbynum diagnosedprevalenceofalzheimersdiseaseandrelateddementiasinmedicareadvantageplans AT susanlmitchell diagnosedprevalenceofalzheimersdiseaseandrelateddementiasinmedicareadvantageplans AT noellemcocoros diagnosedprevalenceofalzheimersdiseaseandrelateddementiasinmedicareadvantageplans AT orenshapira diagnosedprevalenceofalzheimersdiseaseandrelateddementiasinmedicareadvantageplans AT kevinhaynes diagnosedprevalenceofalzheimersdiseaseandrelateddementiasinmedicareadvantageplans AT vinitpnair diagnosedprevalenceofalzheimersdiseaseandrelateddementiasinmedicareadvantageplans AT cherylnmcmahillwalraven diagnosedprevalenceofalzheimersdiseaseandrelateddementiasinmedicareadvantageplans AT richardplatt diagnosedprevalenceofalzheimersdiseaseandrelateddementiasinmedicareadvantageplans AT ellenpmccarthy diagnosedprevalenceofalzheimersdiseaseandrelateddementiasinmedicareadvantageplans |
_version_ |
1721526274222981120 |